Cargando…

Serum BMP-2 and BMP-4 levels and their relationship with disease activity in patients with rheumatoid arthritis and ankylosing spondylitis

OBJECTIVES: This study aims to investigate the levels of bone morphogenic proteins (BMPs), one of the pathways affecting bone turnover in these diseases, and to investigate their relationship with disease activity. PATIENTS AND METHODS: Between September 2013 and July 2015, a total of 100 ankylosing...

Descripción completa

Detalles Bibliográficos
Autores principales: Özdemirel, Ali Erhan, Güven, Serdar Can, Sarı Sürmeli, Zühre, Özyuvalı, Ayla, Kurt, Memet, Rüstemova, Diana, Yalçın Sayan, Ayşe Peyman, Tutkan, Hüseyin, Ataman, Şebnem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Turkish League Against Rheumatism 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791556/
https://www.ncbi.nlm.nih.gov/pubmed/36589602
http://dx.doi.org/10.46497/ArchRheumatol.2022.9819
_version_ 1784859432185757696
author Özdemirel, Ali Erhan
Güven, Serdar Can
Sarı Sürmeli, Zühre
Özyuvalı, Ayla
Kurt, Memet
Rüstemova, Diana
Yalçın Sayan, Ayşe Peyman
Tutkan, Hüseyin
Ataman, Şebnem
author_facet Özdemirel, Ali Erhan
Güven, Serdar Can
Sarı Sürmeli, Zühre
Özyuvalı, Ayla
Kurt, Memet
Rüstemova, Diana
Yalçın Sayan, Ayşe Peyman
Tutkan, Hüseyin
Ataman, Şebnem
author_sort Özdemirel, Ali Erhan
collection PubMed
description OBJECTIVES: This study aims to investigate the levels of bone morphogenic proteins (BMPs), one of the pathways affecting bone turnover in these diseases, and to investigate their relationship with disease activity. PATIENTS AND METHODS: Between September 2013 and July 2015, a total of 100 ankylosing spondylitis (AS) patients (53 males, 48 females; median age: 40 years; range, 18 to 62 years), 58 rheumatoid arthritis (RA) patients (25 males, 33 females; median age: 40.5 years; range, 26 to 59 years), and 102 age- and sex-matched healthy controls (55 males, 47 females; median age: 38 years; range, 18 to 55 years) were included in the study. In all groups, serum BMP-2 and BMP-4 levels were measured using enzyme-linked immunosorbent assay (ELISA). Demographic data (age, sex, duration of disease) and acute phase reactants of the patients at the final visit were recorded. Disease activity was assessed through the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Ankylosing Spondylitis Disease Activity Score C-Reactive Protein (ASDAS-CRP) for AS patients and through the Disease Activity Score-28-CRP (DAS-28-CRP) for RA patients. RESULTS: The median BMP-2 values were found to be significantly higher in the RA group compared to the other groups and in the control group compared to the AS group (p<0.001 for both). There was no significant difference between the groups in terms of median BMP-4 values (p>0.05). No significant relationship was found between serum BMP-2 and BMP-4 levels and disease activity in both AS and RA patients, while there was a weak positive correlation between erythrocyte sedimentation rate and CRP levels with BMP-2 level in RA patients (p=0.014, r=0.320 and p=0.029, r=0.287, respectively). CONCLUSION: Our study results suggest that the BMP pathway may have different dual effects in AS and RA patients depending on the underlying pathogenesis, and that local effects are more prominent than serum levels.
format Online
Article
Text
id pubmed-9791556
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Turkish League Against Rheumatism
record_format MEDLINE/PubMed
spelling pubmed-97915562022-12-30 Serum BMP-2 and BMP-4 levels and their relationship with disease activity in patients with rheumatoid arthritis and ankylosing spondylitis Özdemirel, Ali Erhan Güven, Serdar Can Sarı Sürmeli, Zühre Özyuvalı, Ayla Kurt, Memet Rüstemova, Diana Yalçın Sayan, Ayşe Peyman Tutkan, Hüseyin Ataman, Şebnem Arch Rheumatol Original Article OBJECTIVES: This study aims to investigate the levels of bone morphogenic proteins (BMPs), one of the pathways affecting bone turnover in these diseases, and to investigate their relationship with disease activity. PATIENTS AND METHODS: Between September 2013 and July 2015, a total of 100 ankylosing spondylitis (AS) patients (53 males, 48 females; median age: 40 years; range, 18 to 62 years), 58 rheumatoid arthritis (RA) patients (25 males, 33 females; median age: 40.5 years; range, 26 to 59 years), and 102 age- and sex-matched healthy controls (55 males, 47 females; median age: 38 years; range, 18 to 55 years) were included in the study. In all groups, serum BMP-2 and BMP-4 levels were measured using enzyme-linked immunosorbent assay (ELISA). Demographic data (age, sex, duration of disease) and acute phase reactants of the patients at the final visit were recorded. Disease activity was assessed through the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Ankylosing Spondylitis Disease Activity Score C-Reactive Protein (ASDAS-CRP) for AS patients and through the Disease Activity Score-28-CRP (DAS-28-CRP) for RA patients. RESULTS: The median BMP-2 values were found to be significantly higher in the RA group compared to the other groups and in the control group compared to the AS group (p<0.001 for both). There was no significant difference between the groups in terms of median BMP-4 values (p>0.05). No significant relationship was found between serum BMP-2 and BMP-4 levels and disease activity in both AS and RA patients, while there was a weak positive correlation between erythrocyte sedimentation rate and CRP levels with BMP-2 level in RA patients (p=0.014, r=0.320 and p=0.029, r=0.287, respectively). CONCLUSION: Our study results suggest that the BMP pathway may have different dual effects in AS and RA patients depending on the underlying pathogenesis, and that local effects are more prominent than serum levels. Turkish League Against Rheumatism 2022-08-02 /pmc/articles/PMC9791556/ /pubmed/36589602 http://dx.doi.org/10.46497/ArchRheumatol.2022.9819 Text en Copyright © 2022, Turkish League Against Rheumatism https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Article
Özdemirel, Ali Erhan
Güven, Serdar Can
Sarı Sürmeli, Zühre
Özyuvalı, Ayla
Kurt, Memet
Rüstemova, Diana
Yalçın Sayan, Ayşe Peyman
Tutkan, Hüseyin
Ataman, Şebnem
Serum BMP-2 and BMP-4 levels and their relationship with disease activity in patients with rheumatoid arthritis and ankylosing spondylitis
title Serum BMP-2 and BMP-4 levels and their relationship with disease activity in patients with rheumatoid arthritis and ankylosing spondylitis
title_full Serum BMP-2 and BMP-4 levels and their relationship with disease activity in patients with rheumatoid arthritis and ankylosing spondylitis
title_fullStr Serum BMP-2 and BMP-4 levels and their relationship with disease activity in patients with rheumatoid arthritis and ankylosing spondylitis
title_full_unstemmed Serum BMP-2 and BMP-4 levels and their relationship with disease activity in patients with rheumatoid arthritis and ankylosing spondylitis
title_short Serum BMP-2 and BMP-4 levels and their relationship with disease activity in patients with rheumatoid arthritis and ankylosing spondylitis
title_sort serum bmp-2 and bmp-4 levels and their relationship with disease activity in patients with rheumatoid arthritis and ankylosing spondylitis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791556/
https://www.ncbi.nlm.nih.gov/pubmed/36589602
http://dx.doi.org/10.46497/ArchRheumatol.2022.9819
work_keys_str_mv AT ozdemirelalierhan serumbmp2andbmp4levelsandtheirrelationshipwithdiseaseactivityinpatientswithrheumatoidarthritisandankylosingspondylitis
AT guvenserdarcan serumbmp2andbmp4levelsandtheirrelationshipwithdiseaseactivityinpatientswithrheumatoidarthritisandankylosingspondylitis
AT sarısurmelizuhre serumbmp2andbmp4levelsandtheirrelationshipwithdiseaseactivityinpatientswithrheumatoidarthritisandankylosingspondylitis
AT ozyuvalıayla serumbmp2andbmp4levelsandtheirrelationshipwithdiseaseactivityinpatientswithrheumatoidarthritisandankylosingspondylitis
AT kurtmemet serumbmp2andbmp4levelsandtheirrelationshipwithdiseaseactivityinpatientswithrheumatoidarthritisandankylosingspondylitis
AT rustemovadiana serumbmp2andbmp4levelsandtheirrelationshipwithdiseaseactivityinpatientswithrheumatoidarthritisandankylosingspondylitis
AT yalcınsayanaysepeyman serumbmp2andbmp4levelsandtheirrelationshipwithdiseaseactivityinpatientswithrheumatoidarthritisandankylosingspondylitis
AT tutkanhuseyin serumbmp2andbmp4levelsandtheirrelationshipwithdiseaseactivityinpatientswithrheumatoidarthritisandankylosingspondylitis
AT atamansebnem serumbmp2andbmp4levelsandtheirrelationshipwithdiseaseactivityinpatientswithrheumatoidarthritisandankylosingspondylitis